Innocan Pharma Corp (INNPF) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	6.82M	4.99M	6.46M	5.25M
Cost of goods sold	631.00K	558.00K	575.00K	481.00K
Cost of revenue	631.00K	558.00K	575.00K	481.00K
Research and development expenses	415.00K	161.00K	184.00K	-9.00K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.99M	5.19M	6.49M	5.29M
Operating expense	7.41M	5.35M	6.68M	5.28M
Total operating expenses	8.04M	5.91M	7.25M	5.76M
Operating income	-1.22M	-922.00K	-786.00K	-508.00K
Other non operating income	-200.00K	1.93M	7.00K	330.00K
EBT including unusual items	-1.43M	1.59M	-822.00K	-214.00K
EBT excluding unusual items	-1.30M	1.00M	-786.00K	-184.00K
Income tax expense	220.00K	-262.00K	64.00K	-64.00K
Effective tax rate	-15.36%	-16.45%	-7.79%	29.91%
Other operating expenses	-	-	-	-
Net income	-1.95M	2.00M	-972.00K	-34.00K
Net profit margin	-28.54%	40.00%	-15.03%	-0.65%
Earnings per share	-	-	-	-
Interest and investment income	7.00K	-	-	10.00K
Interest expense	-	-3.00K	-7.00K	-16.00K
Net interest expenses	7.00K	-3.00K	-7.00K	-6.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-1.21M	-910.00K	-778.00K	-503.00K
Gain or loss from assets sale	-	-	-	-

Finance